{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:21Z","timestamp":1790916801476,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.atherosclerosis.2010.06.002","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T04:34:26Z","timestamp":1276317266000},"page":"351-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity"],"prefix":"10.1016","volume":"212","author":[{"given":"Yunfei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nygard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/ars.2005.7.547","article-title":"Homocysteine and redox signaling","volume":"7","author":"Zou","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0015","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","article-title":"Mechanisms of homocysteine-induced oxidative stress","volume":"289","author":"Tyagi","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0020","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1016\/j.febslet.2008.10.030","article-title":"Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes\/macrophages","volume":"582","author":"Dai","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0025","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1006\/bbrc.1995.2856","article-title":"Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell","volume":"217","author":"Cha","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbrc.2008.04.101","article-title":"Thioredoxin as a reducing agent for mammalian methionine sulfoxide reductases B lacking resolving cysteine","volume":"371","author":"Kim","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0035","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1021\/bi700442r","article-title":"The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila","volume":"46","author":"Cheng","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","article-title":"Thioredoxin","volume":"54","author":"Holmgren","year":"1985","journal-title":"Annu Biochem Rev"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1042\/bj20030275","article-title":"Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1","volume":"373","author":"Song","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0050","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1042\/BST0331375","article-title":"Thiol redox control via thioredoxin and glutaredoxin systems","volume":"33","author":"Holmgren","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0076-6879(02)47023-1","article-title":"Mammalian thioredoxin reductases as hydroperoxide reductases","volume":"347","author":"Zhong","year":"2002","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0060","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1074\/jbc.270.20.11761","article-title":"Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols","volume":"270","author":"Bjornstedt","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0065","doi-asserted-by":"crossref","first-page":"22607","DOI":"10.1074\/jbc.272.36.22607","article-title":"Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase","volume":"272","author":"May","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrm2764","article-title":"Protein denitrosylation: enzymatic mechanisms and cellular functions","volume":"10","author":"Benhar","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0075","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Arner","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.atherosclerosis.2005.06.034","article-title":"Oxidized LDL induces a coordinated up-regulation of the glutathione and thioredoxin systems in human macrophages","volume":"185","author":"Hagg","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0085","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/ars.2000.2.4-717","article-title":"Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes","volume":"2","author":"Sahaf","year":"2000","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2169\/internalmedicine.44.1127","article-title":"Increased plasma levels of thioredoxin in patients with glucose intolerance","volume":"44","author":"Miyamoto","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/clc.4960261208","article-title":"Increased plasma thioredoxin in patients with acute myocardial infarction","volume":"26","author":"Soejima","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.atherosclerosis.2008.03.005","article-title":"Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage","volume":"201","author":"Nishihira","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/clinchem\/41.1.173","article-title":"Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review","volume":"41","author":"Malinow","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/bbrc.2000.3689","article-title":"a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions","volume":"277","author":"Das","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/bbrc.1999.0658","article-title":"Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha","volume":"258","author":"Hashimoto","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0969-2126(96)00079-2","article-title":"Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer","volume":"4","author":"Weichsel","year":"1996","journal-title":"Structure"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0130","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1089\/ars.2007.1771","article-title":"Homocysteine and glutathione peroxidase-1","volume":"9","author":"Lubos","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0135","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1167\/iovs.05-0237","article-title":"Induction of thioltransferase and thioredoxin\/thioredoxin reductase systems in cultured porcine lenses under oxidative stress","volume":"46","author":"Moon","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/emm.2005.62","article-title":"Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells","volume":"37","author":"Lim","year":"2005","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0145","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1096\/fj.08-127662","article-title":"Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver","volume":"23","author":"Lu","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2010.06.002_bib0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ahj.2006.10.042","article-title":"Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure","volume":"153","author":"Baber","year":"2007","journal-title":"Am Heart J"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501000420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501000420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:33:51Z","timestamp":1758155631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501000420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S002191501000420X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.06.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}